Zhuhai Livzon Biomedical Technology Co., Ltd signed the capital increase agreement that it will raise CNY 1,000,000,000 in a round of funding on November 17, 2023. The transaction will include participation from returning investor Livzon Pharmaceutical Group Inc. The transaction has been approved 35th meeting of the eighth board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.98 CNY | -1.32% | +2.99% | +11.34% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.34% | 4.34B | |
+25.83% | 661B | |
+27.22% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.58% | 231B | |
+4.52% | 200B | |
-9.37% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Zhuhai Livzon Biomedical Technology Co., Ltd announced that it expects to receive CNY 1 billion in funding from Livzon Pharmaceutical Group Inc.